Azienda Ospedaliera Unversitaria di Parma

Parma 43126

2 studies enrolling now · 4 studies all time

What they study most

Extensive-stage Small Cell Lung Cancer (ES-SCLC), Kidney Disease, Chronic, Lung Cancer, Non-squamous, Non-small Cell, Neoplasm Metastasis, Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC)

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy — Recruiting now
• Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) — Running, not enrolling
• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling